U.S. Pharma Stock News

Jefferson Capital (JCAP) closed out FY 2025 with fourth quarter revenue of US$154.8 million and net income of US$37.7 million, translating to basic EPS of US$0.65 on a reported basis. The company has seen quarterly revenue move from US$118.9 million in Q4 2024 to US$154.8 million in Q4 2025, while trailing twelve month net income reached US$188.0 million and EPS came in at US$6.26. This sets the stage for investors to focus on how sustainable these earnings and margins might be. With net...

InMode (INMD) has introduced a new US$ share repurchase program, authorizing the buyback of up to 6,380,000 shares, or about 10% of its outstanding stock, using available cash. See our latest analysis for InMode. The buyback news comes after a mixed stretch for investors, with a 1-day share price return of 6.11% and a 7-day share price return of 2.34% contrasting with a year-to-date share price return decline of 8.51% and a 1-year total shareholder return decline of 26.05%. This suggests that...

If you are wondering whether Aeva Technologies' current share price lines up with its real value, you are not alone. This article is here to unpack that question step by step. The stock last closed at US$15.16, with returns of 7.0% over 7 days, 19.0% over 30 days, 18.9% year to date, a very large 1 year return that sits well above 400%, a 3 year return of 84.9%, and a 5 year return of a 79.2% decline. These moves have put Aeva back on many watchlists, as investors reassess how the market is...

If you are wondering whether Coca-Cola FEMSA. de is still offering fair value at around US$97.16 per share, this article will walk through what the current price might be implying about the business. The stock has seen mixed recent returns, with a 6.8% decline over the past week and a 13.7% decline over the last month, set against longer term returns of 2.4% year to date, 13.6% over 1 year, 45.3% over 3 years and 154.2% over 5 years. Recent attention around Coca-Cola FEMSA. de has centered...

Dyne Therapeutics plans to submit an accelerated application for its Duchenne muscular dystrophy drug, targeting a potential commercial launch in early 2027. The company has completed enrollment in its Phase 1/2 trial in myotonic dystrophy type 1 and started a Phase 3 trial for DYNE-101 in DM1. New long term DELIVER trial data report meaningful improvements in lung and cardiac function in patients with Duchenne muscular dystrophy. For investors watching NasdaqGS:DYN, these clinical and...

If you are wondering whether Sally Beauty Holdings is still worth your attention at around US$14.54 per share, this article walks through what that price could mean for value focused investors. The stock is roughly flat year to date with a 0.3% return. However, the 59.4% return over the past year, alongside shorter term moves of a 1.7% decline over 7 days and a 4.5% decline over 30 days, suggests sentiment has shifted more than once recently. Recent coverage has focused on Sally Beauty...

In March 2026, Bumble reported fourth-quarter 2025 results that exceeded revenue and earnings expectations, issued first-quarter 2026 revenue guidance of US$209 million to US$213 million (including US$171 million to US$174 million from the Bumble app), and highlighted stronger profitability despite fewer paying users. The company also unveiled an AI-powered overhaul, including its Bee model, the Dates assistant and the upcoming Bumble 2.0 cloud-native platform, aiming to improve user...

If you are wondering whether Amentum Holdings at US$27.90 is offering fair value or an opportunity, you are not alone in asking what the current price really reflects. The stock has seen a mixed return profile, with a 7% decline over the last week and an 8.2% decline over the last month, while still sitting on a 55.9% return over the past year and an 8.5% decline year to date. Recent news coverage around Amentum has focused on its position in the commercial services space and how investors...

Century Communities' multifamily division, Century Living, has acquired a shovel-ready site in Denver's LoHi neighborhood for a luxury apartment project called The Stevie. Groundbreaking is set to begin imminently, with leasing currently projected to start in 2028. The Stevie represents an expansion for NYSE:CCS further into high-end multifamily development in a central Denver location. Century Communities, listed on the NYSE under ticker CCS, is primarily known for building single-family...

Weis Markets (WMK) has wrapped up FY 2025 with fourth quarter revenue of US$1.3b, basic EPS of US$1.11 and net income of US$28.5m, setting the tone for how investors will read the latest set of numbers. Over recent quarters, revenue has ranged from US$1.20b in Q1 2025 to US$1.30b in Q4 2025, while basic EPS has moved between US$0.74 and US$1.11 over the same period, giving you a clear view of how sales and earnings have tracked through the year. With trailing twelve month net profit margin...

A law firm has launched an investigation into Five9's officers and directors over potential breaches of fiduciary duty to shareholders of NasdaqGM:FIVN. The probe focuses on whether management may have failed to act in shareholders' best interests, which could raise corporate governance concerns. This legal review has not been widely reported yet, making it a fresh development for existing and prospective investors. Five9, listed on NasdaqGM:FIVN, provides cloud contact center software used...

If you are wondering whether Sabra Health Care REIT is still reasonably priced at around US$20.62, you are not alone. The stock's recent performance has put valuation front and center. The share price shows returns of 1.0% over 7 days, 5.2% over 30 days, 7.7% year to date, 27.1% over 1 year and 73.5% over 5 years, which naturally raises questions about what is already baked into the price. Recent coverage has focused on Sabra as a healthcare focused REIT, with investors paying close...

Wealthfront (NasdaqGS:WLTH) is under investigation in a securities class action focused on alleged issues in its IPO disclosures. The inquiry follows the company’s first quarterly report as a public firm, which was followed by a decline in the share price. Substantial net deposit outflows and questions around its new home lending business and ownership structure are central to investor concerns. Investors who experienced losses are assessing potential legal remedies tied to the IPO and...

If you are wondering whether Hub Group's current share price reflects its true value, you are not alone. This article will walk through what the numbers are actually saying about the stock. Hub Group's share price closed at US$34.30, with recent returns showing a 12.1% decline over 7 days, 19.4% decline over 30 days, 19.8% decline year to date, and a 5.9% decline over the past year, while the 5-year return sits at 6.4%. These moves have put Hub Group back on some investors' radars,...

PROG Holdings (NYSE:PRG) used its recent Investor Day to outline a move from a leasing focused model toward a broader consumer access platform powered by technology, AI, and data driven marketing. The company also detailed how applying ASC 606 to its newly acquired Purchasing Power business affects reported revenue, adding clarity on how the deal will show up in future financials. Management framed these updates as a key step in integrating the acquisition and refining capital allocation...

U.S. appeals court overturns a $481 million patent verdict against Gen Digital in a case brought by Columbia University. The court sends the case back to review the validity of the Columbia patents at the center of the dispute. The decision reduces immediate financial pressure on Gen Digital while the underlying patent issues are reconsidered. For Gen Digital (NasdaqGS:GEN), the reversal comes at a time when the share price is $20.68 and recent returns have been weak, including a 20.7%...

If you are wondering whether JBT Marel is priced fairly or offering value right now, this article walks through what the current share price might imply. The stock closed at US$129.64, with a 12.9% decline over the last week and a 21.6% decline over the last 30 days. The 1 year return sits at 5.3% and the 3 year return at 30.4%, against a 5 year return of a 3.3% decline. These mixed returns hint that the market has been reassessing the company, with recent moves likely reflecting changing...

If you are wondering whether BETA Technologies at around US$16.65 is a bargain or a value trap, you are not alone. This article is here to unpack what the current price might be implying. The stock has had a rough patch recently, with a 13.6% decline over the last 7 days, a 14.1% decline over the last 30 days, and a 39.1% decline year to date, which can change how the market views both its potential and its risk. Recent news coverage has focused on BETA Technologies as part of broader...

Universal Health Services (NYSE:UHS) has agreed to acquire virtual behavioral health provider Talkspace in a deal valued at about US$835 million. The transaction is structured as a definitive agreement and is expected to close later in 2026, subject to customary approvals. Talkspace brings a nationwide digital platform focused on behavioral health, which UHS plans to integrate into its existing services. For you as an investor, this move puts a spotlight on how NYSE:UHS is approaching...

Why Codexis Is Back on Investors’ Radar Codexis (CDXS) has drawn fresh attention after reporting fourth quarter 2025 results, with revenue of US$38.92 million and net income of US$9.6 million, alongside new full year 2026 revenue guidance. The company also recently signed an agreement to manufacture 50 grams of siRNA for a pharmaceutical partner using its ECO Synthesis platform, adding a commercial data point around its RNA manufacturing capabilities. See our latest analysis for Codexis. At a...

MGE Energy recently reported stronger-than-expected earnings with solid revenue growth, brought new clean energy assets online, extended its multi-decade dividend-raise streak, and saw director James G. Berbee increase his shareholding through an insider purchase. Together with an at-the-market equity program and fresh analyst commentary on renewables and data center-related demand, these moves point to a company emphasizing financial flexibility, long-term capital returns, and board-level...

Cactus (NYSE:WHD) executives Joel Bender and Scott Bender have disclosed significant insider stock sales in March 2026. The President and the Chairman/CEO together sold more than 200,000 shares, according to recent SEC filings. There have been no insider purchases reported at Cactus over the past year, highlighting a one sided pattern of insider activity. Cactus, which trades on the NYSE under the ticker WHD, last closed at $46.36. The stock is down 7.3% over the past week and 19.1% over...

Why Imperial Petroleum is on investors’ radar right now Imperial Petroleum (IMPP) is getting fresh attention after reporting Q4 2025 results that showed higher sales and net income versus the same quarter a year earlier, alongside steady preferred dividend activity. See our latest analysis for Imperial Petroleum. The recent Q4 2025 report and ongoing preferred dividend payments have arrived alongside a 30 day share price return of 23.20% and a 1 year total shareholder return of 87.80%. This...

PPL Electric Utilities recently filed a joint petition for a non-unanimous settlement with the Pennsylvania Public Utility Commission seeking approval for a base distribution rate increase, which would support system reliability and resilience and, if approved, take effect on July 1, 2026, its first such increase since 2016. This proposed rate adjustment highlights how PPL is trying to balance sizable grid investment needs with customer affordability and regulatory oversight, a combination...